Home › High Blood Pressure › Kentucky › Lexington
High Blood Pressure clinical trials in Lexington, KY
3 studies for High Blood Pressure are looking for participants at sites in and around Lexington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- The Research Group of Lexington, Lexington
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Lexington
- Clinical Trial Site, Versailles · 14 mi away
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
RecruitingPhase 2
- Vanda Investigative Site, Lexington
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL22 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Houston, TX11 studies
- Birmingham, AL11 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- Durham, NC10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Lexington
- Non-Small Cell Lung Cancer23 studies
- Lung Cancer18 studies
- Ovarian Cancer16 studies
- Cancer (all types)14 studies
- Prostate Cancer14 studies
- Breast Cancer14 studies
- Metastatic Cancer11 studies
- Heart Failure11 studies
- Colorectal Cancer11 studies
- Obesity10 studies
- Acute Myeloid Leukemia10 studies
- Melanoma10 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.